- sector
-
6th Annual Pharma Resource Planning and Portfolio Management
Strengthen Portfolio Management While Optimizing Resource Planning Techniques and Maximizing Assets
Event Date: 26-28 Feb 2013
Location: The Rittenhouse Hotel, Philadelphia, PA, United States of America
- key conference speakers
-
Assessing the Underlying Causes of the Current Research & Development Productivity Crisis and the Resulting Impacts
Pasquale Cetera VP, Portfolio Management and Strategy, Merck & Co. Investigating Methods for Modeling a Strategic Portfolio and Identifying Tactical and Organized Portfolio Management Processes
David J. Yonce Director, New Product Incubation , AMS, an Endo health solution Building Innovative Solutions Based in Industry Trends
Anastasia Christianson Senior Director, R&D Information, AstraZeneca Pharmaceuticals Integrating Project and Portfolio Management Capabilities-Buildng for the Future
Mike Shires VP. Project and Portfolio Management, Baxter Healthcare
- key conference topics
-
- Gain insight on effective processes for portfolio management and resource planning with Johnson & Johnson
- Evaluate methods for shaping long term portfolio strategy with Baxter Healthcare Corporation
- Investigate the effects that government regulations have on portfolio management processes with Gilead Sciences, Inc
- Prepare for the challenges faced with forecasting and scenario planning with ArthroCare Corporation
- Understand best practices for coordinating cross functional teams to ensure project optimization with Endo Pharmaceuticals
- key conference features
-
- Three Pre-Conference Workshops Available for Additional Cost:
- Workshop A: Analyzing Techniques to Balance a Portfolio Comprised of Both New Products and Established Drugs with Onyx Pharmaceuticals
- Workshop B: Assessing Strategic and Operational Portfolio Management While Optimizing Techniques for Each Method with Alexion Pharmaceuticals
- Workshop C: Implementation of Portfolio Management - Typical Barriers and How to Overcome Them with Catenion
- conference focus
-
The success of a pharmaceutical company relies on effective portfolio management and resource planning. Increasing amounts of drug discoveries and commercially available therapies have forced pharmaceutical companies to re-evaluate their portfolio successes. Changing regulations and government compliance has also posed a threat to successful resource planning and portfolio management. It is now more important than ever for methods and processes to be put in place to ensure all projects are being evaluated and company assets are being leveraged to their fullest potential.
Why Should You Attend?
This conference will focus on the future direction of portfolio management and resource planning, along with the effects that regulations have on processes and challenges of forecasting for resource planning.
The 2013 edition will cover five main areas:
1. The current landscape of portfolio management and resource planning and preparing for regulatory impacts
2. Utilizing internal resources to strengthen portfolio strategy
3. Processes to achieve a balanced portfolio
4. Leveraging software vendors and contract research organizations (CRO) to improve portfolio management
5. The future of portfolio management and resource planning
Attendees will benefit from a dynamic peer-to-peer presentation format consisting of workshops, interactive panel discussions and case studies. Each network and interactive session will be followed by 10-15 minutes of Q&A affording all in attendance an opportunity to get the answers to questions affecting their business. Moreover, 4+ hours of networking opportunities will supply attendees with benchmarking and best practices sharing amongst their peers.
Here is what others have said:
“Up to date, stimulating and interactive meeting. Enthusiastic audience & high quality speakers.”
-Shire Pharmaceuticals
“Relevant & useful topic from industry perspective.”
-Abbott
“The conference provided a good range of topics on the stated themes of repositioning and pipeline enhancement. The speakers delivered high quality presentations. The conference provided an opportunity for networking.”
-Merck
- conference sponsors
-
Gold Sponsor Visit website >> Silver Sponsor Visit website >> Silver Sponsor Visit website >> Panel Partner Visit website >> Association Partner Project Management Institute Delaware Valley Chapter Visit website >> Association Partner Specialty Pharma Association Visit website >> Media Partner BioCentury Visit website >> Media Partner BioPortfolio Visit website >> Media Partner BioSpace Visit website >> Media Partner CanBiotech Visit website >> Media Partner Contract Pharma Visit website >> Media Partner Cutting Edge Information Visit website >> Media Partner PharmaLeaders Visit website >> Media Partner pharmaphorum Visit website >> Media Partner PharmaVOICE Visit website >> Media Partner PharmCast.com Visit website >>
- who should attend the conference
-
marcus evans invites Heads, Vice Presidents and Directors with responsibilites in:
-Portfolio Management
-Resource Planning
-Portfolio Analysis
-Pipeline Management
-Strategic Business Planning
-Project Management
- the conference venue
- the conference organisers
-
marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.
Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.
- conference speakers
-
Spearheading Resource Management Methods for Small and Mid Sized Companies to Ensure Optimal Execution of Projects and ResourcesTom Rollins MS, MBA
SVP, Program Management & Portfolio Management
Cubist Pharmaceuticals, Inc.
Assessing the Underlying Causes of the Current Research & Development Productivity Crisis and the Resulting ImpactsPasquale Cetera
VP, Portfolio Management and Strategy
Merck & Co.
Investigating Methods for Modeling a Strategic Portfolio and Identifying Tactical and Organized Portfolio Management ProcessesDavid J. Yonce
Director, New Product Incubation
AMS, an Endo health solution
Prioritizing New and Existing Projects to Leverage Company Assets and Ensure all Projects are Assesed During Portfolio ReviewBarry Harnick
Portfolio Manager
Elanco
Strengthening Portfolio Management and Resource Planning Processes and Mitigating the Factors That Affect SuccessDan Baird
Director, Global Portfolio and NPD Effectiveness
Johnson and Johnson Consumer
Evaluating the Impact of Government Regulations on Portfolio Management to Execute Proper Approval Submissions at the Appropriate StagesJoanne Curley Ph.D
Senior Director, Project and Portfolio Management
Gilead Sciences, Inc.
Building Innovative Solutions Based in Industry TrendsAnastasia Christianson
Senior Director, R&D Information
AstraZeneca Pharmaceuticals
Integrating Project and Portfolio Management Capabilities-Buildng for the FutureMike Shires
VP. Project and Portfolio Management
Baxter Healthcare